Glucagon-like peptide (GLP)-2 reduces chemotherapy-associated mortality and enhances cell survival in cells expressing a transfected GLP-2 receptor.
Robin P. Boushey(University of Ottawa), Daniel J. Drucker(Mount Sinai Hospital), Bernardo Yusta(Lunenfeld-Tanenbaum Research Institute)
PubMed
January 15, 2001
Cited by 150
Related Papers
Colorectal Cancer Epidemiology: Incidence, Mortality, Survival, and Risk Factors
|Clinics in Colon and Rectal Surgery|2009|2k
The role of gut hormones in glucose homeostasis
|Journal of Clinical Investigation|2007|611
Pharmacology, Physiology, and Mechanisms of Action of Dipeptidyl Peptidase-4 Inhibitors
|Endocrine Reviews|2014|602
Enhancing Incretin Action for the Treatment of Type 2 Diabetes
|Diabetes Care|2003|578
Practice Parameters for the Management of Rectal Cancer (Revised)
|Diseases of the Colon & Rectum|2013|565